The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosis
Abstract
Haemochromatosis (HH) is a clinically and genetically heterogeneous disease caused by inappropriate iron absorption. Most HH patients are homozygous for the C282Y mutation in the HFE gene. However, penetrance of the C282Y mutation is incomplete, and other genetic factors may well affect the HH phenotype. Ferroportin and TFR2 mutations also cause HH, and two HAMP mutations have recently been reported that causes juvenile haemochromatosis (JH) in the homozygous state. Here, we report evidence for digenic inheritance of HH. We have detected two new HAMP mutations in two different families, in which there is concordance between severity of iron overload and heterozygosity for HAMP mutations when present with the HFE C282Y mutation. In family A, the proband has a JH phenotype and is heterozygous for C282Y and a novel HAMP mutation Met50del IVS2+1(-G). This is a four nucleotide ATGG deletion which causes a frameshift. The proband's unaffected mother is also heterozygous for Met50del IVS2+1(-G), but lacks the C282Y mutation and is heterozygous for the HFE H63D mutation. Met50del IVS2+1(-G) was absent from 642 control chromosomes. In family B, a second novel, less severe HAMP mutation, G71D, was identified. This was detected in the general population at an allele frequency of 0.3%. We propose that the phenotype of C282Y heterozygotes and homozygotes may be modified by heterozygosity for mutations which disrupt the function of hepcidin in iron homeostasis, with the severity of iron overload corresponding to the severity of the HAMP mutation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hepcidin, a urinary antimicrobial peptide synthesized in the liver
Park, C. H., Valore, E. V., Waring, A. J., & Ganz, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008922200 · Cited by 2,168
Pigeon, C., Ilyin, G., Courselaud, B., Leroyer, P., Turlin, B., Brissot, P., & Loréal, O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008923200 · Cited by 1,697 · cited 2×
“Hepcidin is a recently identified antimicrobial peptide synthesized in the liver (19,20) as an 84 amino acid prepropeptide, which is processed to give an active peptide comprising the 25 amino acid C-terminal portion of the molecule (19).”
Nicolas, G., Bennoun, M., Devaux, I., Beaumont, C., Grandchamp, B., Kahn, A., & Vaulont, S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151179498 · Cited by 1,233
Nicolas, G., Chauvet, C., Viatte, L., Danan, J. L., Bigard, X., Devaux, I., Beaumont, C., Kahn, A., & Vaulont, S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215686 · Cited by 1,214
Long-term survival in patients with hereditary hemochromatosis
Niederau, C., Fischer, R., Purschel, A., Stremmel, W., Haussinger, D., & Strohmeyer, G. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8613000 · Cited by 890
Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis
Roetto, A., Papanikolaou, G., Politou, M., Alberti, F., Girelli, D., Christakis, J., Loukopoulos, D., & Camaschella, C. (2003) · Nature Genetics · doi:10.1038/ng1053 · Cited by 860 · cited 3×
“Recently two families have been described where JH segregates with either homozygosity for a frameshift or nonsense mutation in HAMP (18).”
Penetrance of 845G→A (C282Y) HFE hereditary haemochromatosis mutation in the USA
Beutler, E., Felitti, V. J., Koziol, J. A., Ho, N. J., & Gelbart, T. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07447-0 · Cited by 823 · cited 1×
“This has given rise to active debate regarding penetrance and HH (10,11).”
The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22
Camaschella, C., Roetto, A., Calì, A., De Gobbi, M., Garozzo, G., Carella, M., Majorano, N., Totaro, A., & Gasparini, P. (2000) · Nature Genetics · doi:10.1038/75534 · Cited by 803
Triallelic Inheritance in Bardet-Biedl Syndrome, a Mendelian Recessive Disorder
Katsanis, N., Ansley, S. J., Badano, J. L., Eichers, E. R., Lewis, R. A., Hoskins, B. E., Scambler, P. J., Davidson, W. S., Beales, P. L., & Lupski, J. R. (2001) · Science · doi:10.1126/science.1063525 · Cited by 655
Bridle, K. R., Frazer, D. M., Wilkins, S. J., Dixon, J. L., Purdie, D. M., Crawford, D. H., Subramaniam, V. N., Powell, L. W., Anderson, G. J., & Ramm, G. A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12602-5 · Cited by 620
Autosomal-dominant hemochrom-atosis is associated with a mutation in the ferroportin (SLC11A3) gene
Montosi, G., Donovan, A., Totaro, A., Garuti, C., Pignatti, E., Cassanelli, S., Trenor, C. C., Gasparini, P., Andrews, N. C., & Pietrangelo, A. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13468 · Cited by 561
Autosomal-dominant hemochrom-atosis is associated with a mutation in the ferroportin (SLC11A3) gene
Montosi, G., Donovan, A., Totaro, A., Garuti, C., Pignatti, E., Cassanelli, S., Trenor, C. C., Gasparini, P., Andrews, N. C., & Pietrangelo, A. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200113468 · Cited by 557
HFE gene knockout produces mouse model of hereditary hemochromatosis
Zhou, X. Y., Tomatsu, S., Fleming, R. E., Parkkila, S., Waheed, A., Jiang, J., Fei, Y., Brunt, E. M., Ruddy, D. A., Prass, C. E., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2492 · Cited by 521
A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis
Njajou, O. T., Vaessen, N., Joosse, M., Berghuis, B., van Dongen, J. W. F., Breuning, M. H., Snijders, P. J. L. M., Rutten, W. P. F., Sandkuijl, L. A., Oostra, B. A., et al. (2001) · Nature Genetics · doi:10.1038/90038 · Cited by 492
Feder, J. N., Tsuchihashi, Z., Irrinki, A., Lee, V. K., Mapa, F. A., Morikang, E., Prass, C. E., Starnes, S. M., Wolff, R. K., Parkkila, S., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.22.14025 · Cited by 471 · cited 1×
“preventing assembly with b2-microglobulin (28,29).”
Hunter, H. N., Fulton, D. B., Ganz, T., & Vogel, H. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205305200 · Cited by 400
Waheed, A., Parkkila, S., Zhou, X. Y., Tomatsu, S., Tsuchihashi, Z., Feder, J. N., Schatzman, R. C., Britton, R. S., Bacon, B. R., & Sly, W. S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12384 · Cited by 380
Parkkila, S., Waheed, A., Britton, R. S., Bacon, B. R., Zhou, X. Y., Tomatsu, S., Fleming, R. E., & Sly, W. S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13198 · Cited by 336
Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis
Nicolas, G., Viatte, L., Lou, D.-Q., Bennoun, M., Beaumont, C., Kahn, A., Andrews, N. C., & Vaulont, S. (2003) · Nature Genetics · doi:10.1038/ng1150 · Cited by 311 · cited 3×
“The natural mutations and phenotypes observed in our patients are proof of predictions made from mouse models of haemochromatosis that genetic variablility in HAMP might contribute to the wide range in phenotypic variation in HFE C282Y homozygotes (21,22).”
Geography of HFE C282Y and H63D Mutations
Merryweather-Clarke, A. T., Pointon, J. J., Jouanolle, A. M., Rochette, J., & Robson, K. J. H. (2000) · Genetic Testing · doi:10.1089/10906570050114902 · Cited by 305
Self-citationMuckenthaler, M., Roy, C. N., Custodio, Á. O., Miñana, B., deGraaf, J., Montross, L. K., Andrews, N. C., & Hentze, M. W. (2003) · Nature Genetics · doi:10.1038/ng1152 · Cited by 298
Parkkila, S., Waheed, A., Britton, R. S., Feder, J. N., Tsuchihashi, Z., Schatzman, R. C., Bacon, B. R., & Sly, W. S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2534 · Cited by 254
New mutations inactivating transferrin receptor 2 in hemochromatosis type 3
Roetto, A., Totaro, A., Piperno, A., Piga, A., Longo, F., Garozzo, G., Calı̀, A., De Gobbi, M., Gasparini, P., & Camaschella, C. (2001) · Blood · doi:10.1182/blood.v97.9.2555 · Cited by 247
Triallelic inheritance in Bardet-Biedl syndrome, a Mendelian recessive disorder.
Katsanis, N., Ansley, S., Badano, J., Eichers, E., Ra, L., Hoskins, B., Scambler, P. J., Davidson, W. S., Beales, P. L., & Lupski (2002) · UCL Discovery (University College London) · Cited by 240
Juvenile Hemochromatosis Locus Maps to Chromosome 1q
Roetto, A., Totaro, A., Cazzola, M., Cicilano, M., Bosio, S., D'Ascola, G., Carella, M., Zelante, L., Kelly, A. L., Cox, T. M., et al. (1999) · The American Journal of Human Genetics · doi:10.1086/302379 · Cited by 236
HFE mutations, iron deficiency and overload in 10 500 blood donors
Jackson, H. A., Carter, K., Darke, C., Guttridge, M. G., Ravine, D., Hutton, R. D., Napier, J. A., & Worwood, M. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02949.x · Cited by 218
Roy, C. N., Penny, D. M., Feder, J. N., & Enns, C. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.9022 · Cited by 206
Santos, M., Schilham, M. W., Rademakers, L. H., Marx, J. J., de Sousa, M., & Clevers, H. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.5.1975 · Cited by 195
Lebrón, J. A., West, A. P., & Bjorkman, P. J. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3252 · Cited by 182
Fleming, R. E., Holden, C. C., Tomatsu, S., Waheed, A., Brunt, E. M., Britton, R. S., Bacon, B. R., Roopenian, D. C., & Sly, W. S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051630898 · Cited by 182
Whitfield, J. B., Cullen, L. M., Jazwinska, E. C., Powell, L. W., Heath, A. C., Zhu, G., Duffy, D. L., & Martin, N. G. (2000) · The American Journal of Human Genetics · doi:10.1086/302862 · Cited by 160
Digenic inheritance of severe insulin resistance in a human pedigree
Savage, D. B., Agostini, M., Barroso, I., Gurnell, M., Luan, J., Meirhaeghe, A., Harding, A.-H., Ihrke, G., Rajanayagam, O., Soos, M. A., et al. (2002) · Nature Genetics · doi:10.1038/ng926 · Cited by 159
Dupic, F., Fruchon, S., Bensaid, M., Borot, N., Radosavljevic, M., Loreal, O., Brissot, P., Gilfillan, S., Bahram, S., Coppin, H., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.31877 · Cited by 99
Bastin, J. M., Jones, M., O’Callaghan, C. A., Schimanski, L. M., Mason, D. Y., & Townsend, A. (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.01102.x · Cited by 99
Deugnier, Y., Jouanolle, A., Chaperon, J., Moirand, R., Pithois, C., Meyer, J., Pouchard, M., Lafraise, B., Brigand, A., Caserio‐Schönemann, C., et al. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03718.x · Cited by 86
The effect of HFE mutations on serum ferritin and transferrin saturation in the Jersey population
Merryweather‐Clarke, A. T., Worwood, M., Parkinson, L., Mattock, C., Pointon, J. J., Shearman, J. R., & Robson, K. (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00736.x · Cited by 84
Self-citationWillis, G. A., Jennings, B. A., Goodman, E., Fellows, I., & Wimperis, J. Z. (1997) · Blood Cells Molecules and Diseases · doi:10.1006/bcmd.1997.0145 · Cited by 49
Gac, G. L., Dupradeau, F., Mura, C., Jacolot, S., Scotet, V., Esnault, G., Mercier, A., Rochette, J., & Férec, C. (2003) · Blood Cells Molecules and Diseases · doi:10.1016/s1079-9796(03)00036-6 · Cited by 47
Clinical haemochromatosis in HFE mutation carriers
Cox, T. M., Rochette, J., Camaschella, C., Walker, A. P., & Robson, K. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09582-x · Cited by 35
Haemochromatosis mutations in North‐East Scotland
Miedzybrodzka, Z., Loughlin, S., Baty, D. U., Terron, A., Kelly, K., Dean, J., Greaves, M., Pippard, M. J., & Haites, N. E. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01554.x · Cited by 26
Cited by
Papanikolaou, G., & Pantopoulos, K. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.06.021 · Cited by 1,070
Hereditary Hemochromatosis — A New Look at an Old Disease
Pietrangelo, A. (2004) · New England Journal of Medicine · doi:10.1056/nejmra031573 · Cited by 992
Mutations in HFE2 cause iron overload in chromosome 1q–linked juvenile hemochromatosis
Papanikolaou, G., Samuels, M. E., Ludwig, E. H., MacDonald, M. L. E., Franchini, P. L., Dubé, M.-P., Andres, L., MacFarlane, J., Sakellaropoulos, N., Politou, M., et al. (2004) · Nature Genetics · doi:10.1038/ng1274 · Cited by 974
Cooper, D. N., Krawczak, M., Polychronakos, C., Tyler-Smith, C., & Kehrer-Sawatzki, H. (2013) · Human Genetics · doi:10.1007/s00439-013-1331-2 · Cited by 645
Forging a field: the golden age of iron biology.
Andrews, N. C. (2008) · Blood · doi:10.1182/blood-2007-12-077388 · Cited by 623
Metadata
- Authors
- Merryweather-Clarke, A. T.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-07-08
- Volume
- 12
- Issue
- 17
- Pages
- 2241-2247
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2133811201
- Cited by
- 263
- References
- 40
- FWCI
- 15.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.